JB

Jens Buchardt

NA Novo Nordisk A/S: 6 patents #242 of 1,775Top 15%
NA Novo Nordisk Health Care Ag: 2 patents #34 of 131Top 30%
CA Carlsberg A/S: 1 patents #21 of 54Top 40%
Overall (All Time): #570,994 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
9737612 Antagonistic DR3 ligands Mette Dahl Andersen, Peder Lisby Noerby, Kristian Kjaergaard, Albrecht Gruhler, Susanne Nedergaard Grell +7 more 2017-08-22
9713644 Antagonistic DR3 ligands Mette Dahl Andersen, Peder Lisby Noerby, Kristian Kjaergaard, Susanne Nedergaard Grell, Albrecht Gruhler +7 more 2017-07-25
9695226 Growth hormones with prolonged in-vivo efficacy Carsten Behrens, Nils Langeland Johansen, Henrik Sune Andersen, Leif Noerskov-Lauritsen 2017-07-04
9234192 Conjugated proteins Carsten Behrens 2016-01-12
9018166 Conjugated FVIII variants Carsten Behrens, Magali Zundel 2015-04-28
8841249 Growth hormones with prolonged in-vivo efficacy Nils Langeland Johansen, Henrik Sune Andersen, Leif Norskov-Lauritsen 2014-09-23
8765130 Antagonistic DR3 ligands Mette Dahl Andersen, Peder Lisby Noerby, Kristian Kjaergaard, Susanne Nedergaard Grell, Albrecht Gruhler +7 more 2014-07-01
8586532 Method for selectively modifying a protein via transglutaminase catalyzed reaction Nils Langeland Johansen 2013-11-19
7064179 Peg-based macromonomers, chemically inert polymers prepared therefrom and the use of these polymers for organic synthesis and enzyme reactions Morten Meldal, Joerg Rademann 2006-06-20